Related Experiment Videos
Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse
M Coulpier1, M P Junier, M Peschanski
1Institut National de la Santé et de la Recherche Médicale U421, Créteil, France.
Summary
The proto-oncogene Bcl-2 does not prevent pathological motoneuron death in adult wobbler mice. This suggests distinct cellular mechanisms underlie experimental versus pathological motoneuron death.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Motoneuronal death mechanisms remain unclear.
- The bcl-2 proto-oncogene inhibits developmental and experimental motoneuron death in mammals.
- Rodent models offer insights into motoneuron degeneration.
Purpose of the Study:
- To investigate Bcl-2's protective effect against pathological motoneuron death in adult rodents.
- To differentiate between cellular pathways of experimental and pathological motoneuron death.
Main Methods:
- Utilized the wobbler mouse mutant, which exhibits progressive motoneuron degeneration.
- Generated a transgenic hybrid mouse with the wobbler mutation and a human bcl-2 transgene.
- Assessed Bcl-2's impact on motoneuron survival in developmental, axotomy-induced, and pathological contexts.
Main Results:
- Bcl-2 successfully protected against developmental motoneuron death and axotomy-induced death in postnatal facial motoneurons.
- However, Bcl-2 did not alter the pathological motoneuron death observed in adult wobbler mice.
- This differential sensitivity indicates distinct death pathways.
Conclusions:
- Bcl-2 sensitivity distinguishes at least two different motoneuronal death pathways in the wobbler mutant.
- Experimental and pathological motoneuron death likely depend on different cellular mechanisms.
- Findings suggest targeted therapeutic strategies may need to account for specific motoneuron death pathways.